Type of Care:
Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Hospital inpatient/24-hour hospital inpatient
Facility Type:
Psychiatric hospital
Pharmacotherapies:
Chlorpromazine Fluphenazine Haloperidol Loxapine Perphenazine Thiothixene Trifluoperazine Aripiprazole Clozapine Lurasidone Olanzapine Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI
Treatment Approaches:
Activity therapy Cognitive behavioral therapy Dialectical behavior therapy Group therapy Integrated Mental and Substance Use Disorder treatment Telemedicine/telehealth therapy Abnormal involuntary movement scale
Emergency Mental Health Services:
Psychiatric emergency onsite services
Facility Operation (e.g., Private, Public):
Private for-profit organization
Special Programs/Groups Offered:
Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment:
Screening for tobacco use
Testing:
HIV testing TB screening Metabolic syndrome monitoring Testing for Hepatitis B (HBV) Testing for Hepatitis C (HCV) Laboratory testing
Education and Counseling Services:
Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy :
Smoking not permitted
Age Groups Accepted:
Adults Seniors
Facility Vaping Policy:
Vaping not permitted